A Headless CDC
The Trump administration faces the challenge of naming a new director of the Centers for Disease Control and Prevention who can both satisfy the Make America Healthy Again movement and get confirmed by the Senate. Meanwhile, a new Senate bill to rescind the approval of the abortion pill mifepristone is again elevating the abortion debate, which some Republicans would prefer to stay on the back burner until after the midterms. Shefali Luthra of The 19th, Lizzy Lawrence of Stat, and Rachel Cohrs Zhang of Bloomberg News join Ńī¹óåś“«Ć½Ņīl Health Newsā Julie Rovner to discuss the news. Also this week, Rovner interviews Georgetown University Law Centerās Katie Keith about the state of the Affordable Care Act on its 16th anniversary.